Clinical Trials Browser

Glioblastoma

Esophageal Neoplasms

Clinical Stage I Gastric Cancer AJCC v8

Carcinoma, Hepatocellular

Rectal Neoplasms

Sinonasal Squamous Cell Carcinoma

Oropharyngeal Neoplasms

Glioma, Central Nervous System Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Prostatic Neoplasms

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

Anatomic Stage II Breast Cancer AJCC v8

Head and Neck Neoplasms

Diabetes Insipidus, Germinoma

Rhabdomyosarcoma

Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Craniopharyngioma

Stomach Neoplasms

Astrocytoma, Glioblastoma, Gliosarcoma

Pancreatic Neoplasms

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Mouth Neoplasms, Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

SPARE-04

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

REGINA

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

MINT-2

A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

SUGAR

SAMe in Prevention of Oxaliplatin-associated Liver Injury

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

NBI-CAB

IVIM & OLINK in Sarcoma

GIVEN